Ihuman Inc. annual report, Q4 FY2023

Business context and reporting period

iHuman Inc. filed this Form 20-F for the fiscal year ended December 31, 2023; it is an annual report, not a standalone Q4 report. The Cayman Islands holding company provides technology-enabled children’s intellectual-development apps and offline products, primarily in China. Online subscriptions are the main revenue source. Substantially all revenue is generated through the China-based VIE, which iHuman consolidates through contractual arrangements rather than equity ownership.

Financial and operating performance

Amounts below are RMB millions unless noted; U.S. dollar equivalents are as reported. Financial statements are prepared under U.S. GAAP.

• Cost of revenue was RMB296.9 million, or 29.2% of revenue. Operating expenses declined 3.1% to RMB561.4 million: R&D fell 17.9% to RMB257.5 million, sales and marketing rose 27.2% to RMB199.5 million, and G&A was RMB104.3 million.
• Other income, net increased to RMB42.7 million from RMB21.2 million. The filing identifies RMB28.5 million of 2023 interest income and RMB12.4 million of government subsidies.
• Average total monthly active users rose 16.0% to 23.04 million. Paying users declined to 4.27 million from 4.75 million, while revenue per paying user rose to RMB238.7 from RMB207.5. Management attributes the paying-user decline partly to normalization after pandemic-era demand.
• Cash from operations was below net income, with the filing citing a RMB60.5 million decrease in deferred revenue and customer advances as a principal working-capital factor. Investing cash outflow was RMB6.5 million and financing cash outflow RMB9.4 million, principally share repurchases.
• Current assets were RMB1,382.4 million and current liabilities RMB490.8 million. Total liabilities were RMB492.7 million, including RMB318.6 million of deferred revenue and customer advances. The balance sheet shows operating lease liabilities of RMB3.9 million; no borrowings are listed in the supplied financial statements.

Material changes versus the prior comparable period

• Revenue growth was modest, but profitability improved substantially, reflecting lower R&D expense and higher gross margin; marketing expense increased as the company stepped up promotion and brand spending.
• Operating cash flow decreased by RMB16.3 million year over year despite higher net income. Deferred revenue and customer advances fell to RMB318.6 million from RMB379.1 million, which management links to normalization from unusually strong Q4 2022 demand.
• Cash and cash equivalents increased, while total liabilities declined to RMB492.7 million from RMB563.9 million.

Outlook, risks, contingencies and unusual items

• No quantified revenue or earnings guidance is provided. Management intends to continue diversifying products, improving user experience, developing technology and content, and expanding marketing and overseas offerings. It says existing cash and expected operating cash flows should cover anticipated working-capital needs and capital expenditures for at least 12 months from the report date.
• In February 2024, the company approved a special dividend of US$0.02 per ordinary share, or US$0.10 per ADS, totaling approximately US$5.3 million. It also acquired Cosmicrew intellectual-property assets from an affiliate for RMB64.0 million (US$9.0 million). Both are subsequent events, not FY2023 operating results.
• China regulatory risk is central: the company relies on VIE contracts for restricted businesses, and enforceability and future regulatory treatment are uncertain. The company says major educational-app filings were completed as non-AST apps, but classification could be challenged. It also does not hold an Online Publishing Service Permit or an Online Transmission of Audio-Visual Programs License; authorities could interpret future requirements differently.
• Cash mobility is constrained by China’s dividend, reserve, foreign-exchange and remittance rules. At year-end, 62.7% of cash and cash equivalents was held in mainland China, 61.5% was denominated in RMB, and 60.9% was held by the VIE and its subsidiaries. The company reports no dividends from subsidiaries to the holding company in 2021–2023.
• The company believes it was a passive foreign investment company (PFIC) for U.S. tax purposes in 2023 and expects it likely to remain one in the current year, subject to asset composition and ADS price. PCAOB inspection access was restored in 2022, but future loss of access could create HFCAA trading restrictions.
• Management concluded internal control over financial reporting was effective at December 31, 2023. The auditor issued an unqualified opinion on the financial statements, but did not attest to internal control effectiveness because iHuman qualified as an emerging growth company. No material legal proceedings were reported.

Investor facts to verify

• Whether growth in active users and revenue per paying user can offset the decline in paying users, and how much revenue remains concentrated in iHuman Chinese.
• The sustainability of 2023 profitability, including the contribution and recurrence of higher other income, and the effect of increased marketing spending.
• Where cash is held and how much is practically accessible to the Cayman holding company, particularly cash controlled by the VIE.
• Progress on licenses and filings, the regulatory classification of products, and continued enforceability of the VIE contractual arrangements.
• Completion and funding of the Cosmicrew acquisition and special dividend, and any resulting impact on liquidity or related-party oversight.
• Annual PFIC status, PCAOB inspection access, and any implications for U.S. investors or ADS trading.